| # | Title | Journal | Year | Citations |
|---|
| 1 | CircRNA: a novel type of biomarker for cancer | Breast Cancer | 2018 | 598 |
| 2 | Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer | Breast Cancer | 2005 | 587 |
| 3 | An overview of mammographic density and its association with breast cancer | Breast Cancer | 2018 | 186 |
| 4 | Activation of PI3K/Akt signaling and hormone resistance in breast cancer | Breast Cancer | 2006 | 182 |
| 5 | Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome | Breast Cancer | 2012 | 180 |
| 6 | The evolving non-surgical ablation of breast cancer: Mr Guided focused ultrasound (MRgFUS) | Breast Cancer | 2007 | 174 |
| 7 | Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication | Breast Cancer | 2017 | 165 |
| 8 | HER2-directed therapy: current treatment options for HER2-positive breast cancer | Breast Cancer | 2015 | 149 |
| 9 | Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer | Breast Cancer | 2018 | 134 |
| 10 | The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis | Breast Cancer | 2012 | 133 |
| 11 | The use of MR imaging guided focused ultrasound in breast cancer patients; a preliminary phase one study and review | Breast Cancer | 2005 | 132 |
| 12 | In vivo single molecular imaging and sentinel node navigation by nanotechnology for molecular targeting drug-delivery systems and tailor-made medicine | Breast Cancer | 2008 | 130 |
| 13 | Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990–2016: evidence from Global Burden of Disease Study 2016 | Breast Cancer | 2019 | 130 |
| 14 | Mechanism of taxane neurotoxicity | Breast Cancer | 2004 | 124 |
| 15 | Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer | Breast Cancer | 2010 | 123 |
| 16 | Hereditary breast and ovarian cancer (HBOC): review of its molecular characteristics, screening, treatment, and prognosis | Breast Cancer | 2021 | 118 |
| 17 | Pathophysiology of seroma in breast cancer | Breast Cancer | 2005 | 116 |
| 18 | Prognostic significance of NANOG and KLF4 for breast cancer | Breast Cancer | 2014 | 114 |
| 19 | Radiofrequency ablation therapy in patients with breast cancers two centimeters or less in size | Breast Cancer | 2007 | 111 |
| 20 | Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis | Breast Cancer | 2010 | 111 |
| 21 | Diagnostic accuracy of contrast-enhanced spectral mammography in comparison to conventional full-field digital mammography in a population of women with dense breasts | Breast Cancer | 2017 | 106 |
| 22 | Candidate miRNAs in human breast cancer biomarkers: a systematic review | Breast Cancer | 2018 | 106 |
| 23 | Photoacoustic mammography: initial clinical results | Breast Cancer | 2014 | 101 |
| 24 | Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy | Breast Cancer | 2011 | 100 |
| 25 | The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study | Breast Cancer | 2018 | 98 |
| 26 | Prevalence of anxiety among breast cancer patients: a systematic review and meta-analysis | Breast Cancer | 2020 | 97 |
| 27 | Is triple negative a prognostic factor in breast cancer? | Breast Cancer | 2008 | 96 |
| 28 | Analysis of ipsilateral breast tumor recurrences after breast-conserving treatment based on the classification of true recurrences and new primary tumors | Breast Cancer | 2005 | 95 |
| 29 | Evaluation of axillary lymph node status in breast cancer with MRI | Breast Cancer | 1999 | 94 |
| 30 | Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients - evaluation of appropriate research design and methodology to measure symptoms | Breast Cancer | 2005 | 94 |
| 31 | Immunohistochemical evaluation of hormone receptor status for predicting response to endocrine therapy in metastatic breast cancer | Breast Cancer | 2006 | 94 |
| 32 | Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review | Breast Cancer | 2012 | 93 |
| 33 | The relationship between FDG uptake in PET scans and biological behavior in breast cancer | Breast Cancer | 2007 | 91 |
| 34 | Interferon-inducible guanylate binding protein (GBP2) is associated with better prognosis in breast cancer and indicates an efficient T cell response | Breast Cancer | 2014 | 91 |
| 35 | Meta-analysis of the effects of exercise intervention on quality of life in breast cancer survivors | Breast Cancer | 2014 | 91 |
| 36 | Histopathological criteria for assessment of therapeutic response in breast cancer (2007 version) | Breast Cancer | 2008 | 90 |
| 37 | The frequency of low HER2 expression in breast cancer and a comparison of prognosis between patients with HER2-low and HER2-negative breast cancer by HR status | Breast Cancer | 2022 | 90 |
| 38 | Sentinel lymph node mapping in breast cancer | Breast Cancer | 1999 | 89 |
| 39 | Reproductive history and breast cancer risk | Breast Cancer | 2012 | 89 |
| 40 | Gastrointestinal microbiome and breast cancer: correlations, mechanisms and potential clinical implications | Breast Cancer | 2017 | 88 |
| 41 | The therapeutic candidate for immune checkpoint inhibitors elucidated by the status of tumor-infiltrating lymphocytes (TILs) and programmed death ligand 1 (PD-L1) expression in triple negative breast cancer (TNBC) | Breast Cancer | 2018 | 88 |
| 42 | Association ofp53 codon arg72pro andp73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of japanese breast cancer | Breast Cancer | 2003 | 86 |
| 43 | New development in intracrinology of breast carcinoma | Breast Cancer | 2006 | 86 |
| 44 | Focal breast edema associated with malignancy on T2-weighted images of breast MRI: peritumoral edema, prepectoral edema, and subcutaneous edema | Breast Cancer | 2015 | 85 |
| 45 | Atypical cystic lobule of the breast: An early stage of low-grade ductal carcinomain-situ | Breast Cancer | 2000 | 83 |
| 46 | Upregulation and overexpression of human x-box binding protein 1 (hXBP-1) gene in primary breast cancers | Breast Cancer | 2003 | 83 |
| 47 | Ultrasound demonstration of mammographically detected microcalcifications in patients with ductal carcinomain situ of the breast | Breast Cancer | 2005 | 83 |
| 48 | The role of miR-130a in cancer | Breast Cancer | 2017 | 83 |
| 49 | Oncoplastic techniques in the conservative surgical treatment of Breast Cancer | Breast Cancer | 2000 | 82 |
| 50 | A meta-analysis of the benefits of mindfulness-based stress reduction (MBSR) on psychological function among breast cancer (BC) survivors | Breast Cancer | 2016 | 81 |
